常规时段
					
										
  | 
									
										
  | 
									
										
  | 
									
										
  | 	
										
										
  | 
									
									
									
								||||||||||||
  | 
									
										
  | 
								
									
										
  | 
									
										
  | 
									
										
  | 
								
										
  | 
									
										
  | 
									
										
  | 
								
| 价值评估 | 
| 
										 盈利(现时/预测) 
										
												-3.41/-4.16										 
									 | 
								
| 
										 企业价值 
										
											5.05B										 
									 | 
								
| 资产负债 | 
| 
											 每股账面净值 
											
												7.07											 
										 | 
									
| 现金流量 | 
| 
											 现金流量率 	
											
																					--											 
										 | 
									
| 损益表 | 
| 
											 收益 
											 
													107.94M											 
										 | 
									
| 
											 每股收益 
											
												0.58											 
										 | 
									
| 
	   					 同行比较 
	   					
	   				 | 
	   			||||||||||||||||||||||||||||||||||||||||||||||||
  | 
		   		
 
																报价延迟最少15分钟:2025/11/04 02:36 EST
														同行比较之报价最少15分钟延迟
											| 
						 业务概览 
					 | 
				|||
| Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors. | 

				
						
 86.13														
